Скачать или смотреть From Scans to Strategy: Imaging and Risk Assessment in Advanced Prostate Cancer

A regional roundtable discussion, moderated by Mark Delworth, MD, The Urology Group, explored the evolving landscape of advanced prostate cancer management, including imaging innovations, treatment sequencing, biomarker integration, and patient-centered decision-making. Dr. Delworth was joined by other practitioners at The Urology Group, including Brian Minnillo, MD; Robert Larke, MD; Brooke Edwards, MD; and Stephen Bennett, MD.

In the second segment, the panel discusses imaging and early indicators of disease progression in metastatic castration-sensitive prostate cancer. They focus on the use of PSMA PET scans versus conventional imaging, the potential for false positives, and key markers such as PSA response, tumor aggressiveness, and genetic mutations that may signal a higher risk for castration-resistant disease.